Additionally, whilst monitoring CH2 stock levels of Neuvis, it appears the cost to buy in each unit has been further reduced, despite already a very reasonable price in comparison to competitors. I guess they weren’t joking when they stated stable, consistent, cost effective, clinically validated medicine was their goal.
Additionally, whilst monitoring CH2 stock levels of Neuvis, it...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)